Citation Impact
Citing Papers
Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA
2004 StandoutScience
Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
2003
Identification of the haematopoietic stem cell niche and control of the niche size
2003 StandoutNature
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Hallmarks of Cancer: The Next Generation
2011 Standout
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
A gene expression database for the molecular pharmacology of cancer
2000 Nobel
IRF-7 is the master regulator of type-I interferon-dependent immune responses
2005 StandoutNature
Southwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth Factors
1993
c‐kit+ FcR+ myelocytes are increased in cancer and prevent the proliferation of fully cytolytic T cells in the presence of immune serum
2002
Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1
1996 StandoutNature
Systematic variation in gene expression patterns in human cancer cell lines
2000 Standout
Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity
2006
Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment
2002
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
2005 StandoutNature
The α(1,3)Fucosyltransferase Fuc-TVII Controls Leukocyte Trafficking through an Essential Role in L-, E-, and P-selectin Ligand Biosynthesis
1996
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family
1995
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
RANK is essential for osteoclast and lymph node development
1999
Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology
2001
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
2002 StandoutNature
A family of cytokine-inducible inhibitors of signalling
1997 StandoutNature
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
2007 StandoutNature
Variable expression of CD3‐ζ chain in tumor‐infiltrating lymphocytes (TIL) derived from renal‐cell carcinoma: Relationship with til phenotype and function
1995
Central nervous system control of food intake
2000 StandoutNature
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Immunity, Inflammation, and Cancer
2010 Standout
The ikaros gene is required for the development of all lymphoid lineages
1994
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche
2010 StandoutNature
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
1998 StandoutNature
Osteoclast differentiation and activation
2003 StandoutNature
Infectious and immunosuppressive complications of purine analog therapy.
1995
B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40
1993 StandoutNatureNobel
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
Molecular portraits of human breast tumours
2000 StandoutNature
Cancer immunotherapy comes of age
2011 StandoutNature
Management of Metastatic Melanoma 2005
2006
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
2007
Predicting drug sensitivity and resistance
2004
A protein expression database for the molecular pharmacology of cancer
1997
Preclinical evaluation of 9-chloro-2-methylellipticinium acetate alone and in combination with conventional anticancer drugs for the treatment of human brain tumor xenografts
1998
Cytoplasmic domains of the common beta -chain of the GM-CSF/IL-3/IL-5 receptors that are required for inducing differentiation or clonal suppression in myeloid leukaemic cell lines
1997
Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression
1995
BRAF mutation predicts sensitivity to MEK inhibition
2005 Nature
In vivo cultivation of tumor cells in hollow fibers
1995
Points of control in inflammation
2002 StandoutNature
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Leptin and the regulation of body weight in mammals
1998 StandoutNature
Transgenic Mice and Analysis of B-Cell Tolerance
1992
Adoptive-cell-transfer therapy for the treatment of patients with cancer
2003
The NCI60 human tumour cell line anticancer drug screen
2006 Standout
Studies in listeriosis show the strong symbiosis between the innate cellular system and the T‐cell response
1997
In vivoblockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance
1999 StandoutNobel
Vitamin A deficiency in mice causes a systemic expansion of myeloid cells
2000
Mouse Strain Differences in Plasmacytoid Dendritic Cell Frequency and Function Revealed by a Novel Monoclonal Antibody
2003
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen
1995 Standout
Karyotypic complexity of the NCI-60 drug-screening panel.
2003
Identification of properties that can distinguish primitive populations of stromal-cell-responsive lympho-myeloid cells from cells that are stromal-cell-responsive but lymphoid-restricted and cells that have lympho-myeloid potential but are also capable of competitively repopulating myeloablated recipients
1996
Targeted and Equally Distributed Delivery of mRNA to Organs with Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers
2023 StandoutNobel
Peptidic degron for IMiD-induced degradation of heterologous proteins
2019 StandoutNobel
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T Cells
1995 StandoutScience
Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection.
1995
Changes in Plasma Leptin during the Treatment of Diabetic Ketoacidosis
1999
Gr-1+ Myeloid Cells Derived from Tumor-Bearing Mice Inhibit Primary T Cell Activation Induced Through CD3/CD28 Costimulation
2000
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Three proteins involved in Caenorhabditis elegans vulval invagination are similar to components of a glycosylation pathway
1999 StandoutNobel
Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches
2001
Requirement of Mip-1α for an Inflammatory Response to Viral Infection
1995 StandoutScienceNobel
Preferential Migration of Activated CD4 + and CD8 + T Cells in Response to MIP-1α and MIP-1β
1993 Science
Expression Levels of B Cell Surface Immunoglobulin Regulate Efficiency of Allelic Exclusion and Size of Autoreactive B-1 Cell Compartment
1999 StandoutNobel
Essential Role of Neutrophils in the Initiation and Progression of a Murine Model of Rheumatoid Arthritis
2001
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Functional DNA–Polymer Conjugates
2021
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
1997 StandoutScience
Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection
2004 StandoutNobel
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow
1998 Nobel
Identification of properties that can distinguish primitive populations of stromal-cell-responsive lympho-myeloid cells from cells that are stromal-cell-responsive but lymphoid-restricted and cells that have lympho-myeloid potential but are also capable of competitively repopulating myeloablated recipients
1996
Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species
2004
Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays
2003
Polysialic acid governs T-cell development by regulating progenitor access to the thymus
2009 StandoutNobel
Mice Bearing Late-Stage Tumors Have Normal Functional Systemic T Cell Responses In Vitro and In Vivo
2000
Alterations in Signal Transduction Molecules in T Lymphocytes from Tumor-Bearing Mice
1992 Science
Apoptotic Death of CD8+ T Lymphocytes After Immunization: Induction of a Suppressive Population of Mac-1+/Gr-1+ Cells
1998
Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion
2007
CD8+ and CD45RA+ human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1α, interleukin‐8 and RANTES
1995
JNK1 controls mast cell degranulation and IL-1β production in inflammatory arthritis
2010 StandoutNobel
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
1999 StandoutNobel
Works of William C. Kopp being referenced
Characterization of Effect of Repeated Freeze and Thaw Cycles on Stability of Genomic DNA Using Pulsed Field Gel Electrophoresis
2012
Kinetics of Recovery of CD4+ T Cells in Peripheral Blood of Deoxycoformycin-Treated Patients
1991
Immunomodulatory Effects of Interferon-?? in Patients with Metastatic Malignant Melanoma
1993
Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Advanced Malignancy: A Phase Ib Trial
1990
Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer.
1998
Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells.
1991
Immunomodulatory properties and toxicity of interleukin 2 in patients with cancer.
1990
Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia.
1989
Alteration of the B cell surface phenotype, immune response to phosphocholine and the B cell repertoire in M167 mu plus kappa transgenic mice.
1989
Immunoregulation in cancer-bearing hosts. Down-regulation of gene expression and cytotoxic function in CD8+ T cells
1992
Interleukin 1α Increases Serum Leptin Concentrations in Humans
1997
Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen.
1992
Enhanced lymphokine production and lymphokine receptor expression in multiple antibody-stimulated human CD4+ peripheral blood lymphocytes.
1992